等待开盘 08-20 09:30:00 美东时间
-0.010
-0.05%
今日重点评级关注:古根海姆:维持Scynexis"买入"评级,目标价从24美元升至33美元;韦德布什:维持Kura Oncology"跑赢大市"评级,目标价从36美元升至38美元
08-14 11:51
华盛资讯8月13日讯,National Vision公布2026财年Q3业绩,公司Q3营收4.99亿美元,同比增长2.7%,归母净利润0.12亿美元,同比增长33.3%。
08-13 20:32
The most oversold stocks in the consumer discretionary sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, ...
08-13 18:20
National Vision Holdings shares are trading lower after the company reported mixed Q2 financial results.
08-12 22:13
华盛资讯8月12日讯,National Vision公布2026财年Q3业绩,公司Q3营收4.99亿美元,同比增长2.5%,归母净利润0.12亿美元,同比增长42.3%。
08-12 18:17
National Vision Holdings (NASDAQ:EYE) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $0.19 by 31.58 percent. This is a 38.89 percent increase over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $498.805...
08-12 18:01
National Vision Holdings (NASDAQ:EYE) raises FY2026 Adj EPS guidance from $0.85-$1.09 to $0.94-$1.09 vs $0.97 analyst estimate. Narrows FY2026 sales outlook from $2.033 billion-$2.091 billion to $2.037 billion-$2.076 billion vs $2.068 billion estimate.
08-12 18:00
National Vision 2026财年第二季度营收增长2.5%至4.988亿美元,摊薄后每股收益从0.11美元增至0.15美元。调整后营业利润增长32.7%至3160万美元,调整后营业利润率从4.9%提升至6.3%,主要由于员工相关费用和广告费用的减少足以抵消营业成本率上升的影响。客单价提升和管理式医疗业务支撑了同店销售额增长,但自费客流量依然疲软。该公司将其调整后同店销售额增长预期收窄至3.0%-5.0%,并维持开设30至35家新门店的计划。
08-12 10:04
英伟达连涨五日创近两个月新高!多张Call单升逾200%;AMD绩后重挫逾7%,热门Call单押注股价超跌反弹>>
08-06 19:37
尽管Meta与百思买的合作可能对其他眼镜零售商产生潜在影响,但高盛认为,该行追踪的三家眼镜零售商提供的服务与Meta Lab存在足够差异,因此受到影响有限。
06-17 14:48